BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 31760547)

  • 1. Counseling young women with early breast cancer on fertility preservation.
    Ter Welle-Butalid MEE; Vriens IJHI; Derhaag JGJ; Leter EME; de Die-Smulders CEC; Smidt MM; van Golde RJTR; Tjan-Heijnen VCGV
    J Assist Reprod Genet; 2019 Dec; 36(12):2593-2604. PubMed ID: 31760547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FERTILITY PRESERVATION IN YOUNG WOMEN WITH EARLY-STAGE BREAST CANCER.
    Vuković P; Kasum M; Raguž J; Lonjak N; Bilić Knežević S; Orešković I; Beketić Orešković L; Čehić E
    Acta Clin Croat; 2019 Mar; 58(1):147-156. PubMed ID: 31363337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fertility preservation options in breast cancer patients.
    Kasum M; von Wolff M; Franulić D; Čehić E; Klepac-Pulanić T; Orešković S; Juras J
    Gynecol Endocrinol; 2015; 31(11):846-51. PubMed ID: 26370157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
    Danis RB; Pereira N; Elias RT
    Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of women and girls undergoing fertility preservation due to oncologic and non-oncologic indications in Sweden-Trends in patients' choices and benefit of the chosen methods after long-term follow up.
    Rodriguez-Wallberg KA; Marklund A; Lundberg F; Wikander I; Milenkovic M; Anastacio A; Sergouniotis F; Wånggren K; Ekengren J; Lind T; Borgström B
    Acta Obstet Gynecol Scand; 2019 May; 98(5):604-615. PubMed ID: 30723910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Techniques for fertility preservation in patients with breast cancer.
    Dunn L; Fox KR
    Curr Opin Obstet Gynecol; 2009 Feb; 21(1):68-73. PubMed ID: 19125006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fertility after breast cancer treatment.
    Kasum M; Beketić-Orešković L; Peddi PF; Orešković S; Johnson RH
    Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():13-8. PubMed ID: 24315568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fertility Preservation Success Subsequent to Concurrent Aromatase Inhibitor Treatment and Ovarian Stimulation in Women With Breast Cancer.
    Oktay K; Turan V; Bedoschi G; Pacheco FS; Moy F
    J Clin Oncol; 2015 Aug; 33(22):2424-9. PubMed ID: 26101247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian response and follow-up outcomes in women diagnosed with cancer having fertility preservation: Comparison of random start and early follicular phase stimulation - cohort study.
    Muteshi C; Child T; Ohuma E; Fatum M
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():10-14. PubMed ID: 30227359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response.
    Alvarez RM; Ramanathan P
    Hum Reprod; 2018 Nov; 33(11):2051-2059. PubMed ID: 27370358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COH outcomes in breast cancer patients for fertility preservation: a comparison with the expected response by age.
    Malacarne E; Devesa M; Martinez F; Rodriguez I; Coroleu B
    J Assist Reprod Genet; 2020 Dec; 37(12):3069-3076. PubMed ID: 32945994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response.
    Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W
    Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer.
    Porcu E; Cillo GM; Cipriani L; Sacilotto F; Notarangelo L; Damiano G; Dirodi M; Roncarati I
    J Assist Reprod Genet; 2020 Mar; 37(3):709-715. PubMed ID: 31872386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.
    Rodgers RJ; Reid GD; Koch J; Deans R; Ledger WL; Friedlander M; Gilchrist RB; Walters KA; Abbott JA
    Hum Reprod; 2017 May; 32(5):1033-1045. PubMed ID: 28333356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fertility preservation and pregnancy in women with and without BRCA mutation-positive breast cancer.
    Rodriguez-Wallberg KA; Oktay K
    Oncologist; 2012; 17(11):1409-17. PubMed ID: 23006497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro.
    Grynberg M; Dagher Hayeck B; Papanikolaou EG; Sifer C; Sermondade N; Sonigo C
    Hum Reprod; 2019 Feb; 34(2):374-379. PubMed ID: 30561604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of letrozole administration on oocyte morphology in breast cancer patients undergoing fertility preservation.
    Bercaire LMN; Cavagna M; Donadio NF; Rocha AR; Portela R; Alves VR; Santos TBB; Cavagna F; Dzik A; Gebrim LH; Nahas EAP
    JBRA Assist Reprod; 2020 Jul; 24(3):257-264. PubMed ID: 32293820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fertility preservation in women harboring deleterious BRCA mutations: ready for prime time?
    Peccatori FA; Mangili G; Bergamini A; Filippi F; Martinelli F; Ferrari F; Noli S; Rabaiotti E; Candiani M; Somigliana E
    Hum Reprod; 2018 Feb; 33(2):181-187. PubMed ID: 29207007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic treatment.
    Creux H; Monnier P; Son WY; Tulandi T; Buckett W
    Fertil Steril; 2017 Jan; 107(1):198-204. PubMed ID: 27810160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience.
    Vriens IJH; Ter Welle-Butalid EM; de Boer M; de Die-Smulders CEM; Derhaag JG; Geurts SME; van Hellemond IEG; Luiten EJT; Dercksen MW; Lemaire BMD; van Haaren ERM; Vriens BEPJ; van de Wouw AJ; van Riel AMGH; Janssen-Engelen SLE; van de Poel MHW; Schepers-van der Sterren EEM; van Golde RJT; Tjan-Heijnen VCG
    Breast Cancer Res Treat; 2020 May; 181(1):77-86. PubMed ID: 32236826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.